Literature DB >> 18680676

Chikungunya-related fatality rates, Mauritius, India, and Reunion Island.

Philippe Renault, Loic Josseran, Vincent Pierre.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18680676      PMCID: PMC2600376          DOI: 10.3201/eid1408.080201

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: During the epidemic of chikungunya virus infection that occurred on Reunion Island in 2005–06, we reported an overmortality corresponding to the epidemic peak, which was estimated by comparing observed and expected deaths (). The excess was similar to the number of deaths related to chikungunya infection reported by death certificates (). The case-fatality rate (CFR) on Reunion Island was estimated to be 1/1,000 population. According to Beesoon et al. (), the fatality rate attributable to chikungunya infection was much higher on Mauritius: 743 deaths in excess of expected deaths led to a CFR of ≈4.5%, with 15,760 confirmed or suspected cases for 2005 and 2006 as reported in this letter. A similar CFR of 4.9% can be calculated for the city of Ahmedabad, India, during the 2006 chikungunya epidemic (). This 45- to 49-fold difference could be explained by a greater severity of chikungunya infection in Mauritius or Ahmedabad that could be due to a mutating strain, differences in the preexisting conditions of patients, differences in the management of patients, or by coincident deaths in excess from other causes. However, the most probable explanation can be attributed to the surveillance systems of chikungunya cases. On Reunion Island, surveillance was highly sensitive and relied either on active case finding or on estimates of suspected cases. Results have been assessed by iterative external studies and serosurveys, and the CFR we found is likely consistent. If we apply this rate to Mauritius, ≈60% of the population would have contracted chikungunya infection during this epidemic. If so, the risk of epidemic resurgence could be much lower than previously expected. This point raises the need to conduct seroprevalence studies in those territories, the only way to evaluate the herd immunity level of the population.
  4 in total

1.  A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006.

Authors:  Philippe Renault; Jean-Louis Solet; Daouda Sissoko; Elsa Balleydier; Sophie Larrieu; Laurent Filleul; Christian Lassalle; Julien Thiria; Emmanuelle Rachou; Henriette de Valk; Daniele Ilef; Martine Ledrans; Isabelle Quatresous; Philippe Quenel; Vincent Pierre
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

2.  Chikungunya disease outbreak, Reunion Island.

Authors:  Loïc Josseran; Christophe Paquet; Abdelkrim Zehgnoun; Nadège Caillere; Alain Le Tertre; Jean-Louis Solet; Martine Ledrans
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

3.  Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India.

Authors:  Dileep Mavalankar; Priya Shastri; Tathagata Bandyopadhyay; Jeram Parmar; Karaikurichi V Ramani
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

4.  Chikungunya fever, Mauritius, 2006.

Authors:  Sanjay Beesoon; Ellen Funkhouser; Navaratnam Kotea; Andrew Spielman; Rebecca M Robich
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

  4 in total
  27 in total

1.  Genetic Characterization of Northwestern Colombian Chikungunya Virus Strains from the 2014-2015 Epidemic.

Authors:  Juan D Rodas; Tiffany Kautz; Erwin Camacho; Luis Paternina; Hilda Guzmán; Francisco J Díaz; Pedro Blanco; Robert Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

Review 2.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Vector competence of Aedes aegypti and Aedes vittatus (Diptera: Culicidae) from Senegal and Cape Verde archipelago for West African lineages of chikungunya virus.

Authors:  Cheikh T Diagne; Oumar Faye; Mathilde Guerbois; Rachel Knight; Diawo Diallo; Ousmane Faye; Yamar Ba; Ibrahima Dia; Ousmane Faye; Scott C Weaver; Amadou A Sall; Mawlouth Diallo
Journal:  Am J Trop Med Hyg       Date:  2014-07-07       Impact factor: 2.345

4.  Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.

Authors:  Morgan J Hennessey; Esther M Ellis; Mark J Delorey; Amanda J Panella; Olga I Kosoy; Hannah L Kirking; Grace D Appiah; Jin Qin; Alison J Basile; Leora R Feldstein; Brad J Biggerstaff; Robert S Lanciotti; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

5.  Examining the potential for South American arboviruses to spread beyond the New World.

Authors:  Víctor Hugo Peña-García; Michael K McCracken; Rebecca C Christofferson
Journal:  Curr Clin Microbiol Rep       Date:  2017-10-19

Review 6.  Prophylactic strategies to control chikungunya virus infection.

Authors:  Friederike I L Hucke; Malena Bestehorn-Willmann; Joachim J Bugert
Journal:  Virus Genes       Date:  2021-02-15       Impact factor: 2.332

7.  Chikungunya virus infection during pregnancy, Reunion, France, 2006.

Authors:  Xavier Fritel; Olivier Rollot; Patrick Gerardin; Bernard Alex Gauzere; Jacques Bideault; Louis Lagarde; Barbara Dhuime; Eric Orvain; Fabrice Cuillier; Duksha Ramful; Sylvain Samperiz; Marie Christine Jaffar-Bandjee; Alain Michault; Liliane Cotte; Monique Kaminski; Alain Fourmaintraux
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

Review 8.  COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform.

Authors:  Muhammad Umer Ashraf; Yeji Kim; Sunil Kumar; Dongyeob Seo; Maryam Ashraf; Yong-Soo Bae
Journal:  Vaccines (Basel)       Date:  2021-02-18

9.  Seroprevalence of antibodies against Chikungunya, Dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar.

Authors:  Norbert G Schwarz; Mirko Girmann; Njary Randriamampionona; Alexandra Bialonski; Deborah Maus; Anne Caroline Krefis; Christine Njarasoa; Jeanne Fleury Rajanalison; Herly Daniel Ramandrisoa; Maurice Lucien Randriarison; Jürgen May; Jonas Schmidt-Chanasit; Raphael Rakotozandrindrainy
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

Review 10.  Chikungunya Virus-Associated Disease.

Authors:  C Hua; B Combe
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.